NCT00000927View on ClinicalTrials.gov

A Study of BufferGel in Women

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

BufferGel

Trial Locations (1)

02860

Mem Hosp of Rhode Island, Pawtucket

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000927 - A Study of BufferGel in Women | Biotech Hunter | Biotech Hunter